Williams AJK - Search Results

1

Exocrine Proteins Including Trypsin(ogen) as a Key Biomarker in Type 1 Diabetes.

Bakinowska L, Vartak T, Phuthego T, Taylor M, Chandler K, Jerram ST, Williams S, Feldmann M, Johnson DG, Patel KA, Williams AJK, Long AE, Leslie RD, Gillespie KM; Action LADA Consortium; BOX Study Group. Bakinowska L, et al. Among authors: williams ajk. Diabetes Care. 2023 Apr 1;46(4):714-721. doi: 10.2337/dc22-1317. Diabetes Care. 2023. PMID: 36701208

2

Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers.

Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Bingley PJ, et al. Diabetes. 1997 Nov;46(11):1701-10. doi: 10.2337/diab.46.11.1701. Diabetes. 1997. PMID: 9356015

3

Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?

Gardner SG, Gale EA, Williams AJ, Gillespie KM, Lawrence KE, Bottazzo GF, Bingley PJ. Gardner SG, et al. Diabetes Care. 1999 Dec;22(12):2049-54. doi: 10.2337/diacare.22.12.2049. Diabetes Care. 1999. PMID: 10587841

4

The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity.

Williams AJ, Norcross AJ, Lock RJ, Unsworth DJ, Gale EA, Bingley PJ. Williams AJ, et al. Diabetes Care. 2001 Mar;24(3):504-9. doi: 10.2337/diacare.24.3.504. Diabetes Care. 2001. PMID: 11289476

5

The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence.

Williams AJ, Norcross AJ, Dix RJ, Gillespie KM, Gale EA, Bingley PJ. Williams AJ, et al. Diabetologia. 2003 Oct;46(10):1354-6. doi: 10.1007/s00125-003-1197-2. Epub 2003 Sep 9. Diabetologia. 2003. PMID: 13680123

6

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.

Gale EA, Bingley PJ, Emmett CL, Collier T; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. Gale EA, et al. Lancet. 2004 Mar 20;363(9413):925-31. doi: 10.1016/S0140-6736(04)15786-3. Lancet. 2004. PMID: 15043959 Clinical Trial.

7

Non-specific binding to protein A Sepharose and protein G Sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamine.

Williams AJ, Norcross AJ, Chandler KA, Bingley PJ. Williams AJ, et al. J Immunol Methods. 2006 Jul 31;314(1-2):170-3. doi: 10.1016/j.jim.2006.06.003. Epub 2006 Jun 28. J Immunol Methods. 2006. PMID: 16843481

8

Islet autoimmunity in children with Down's syndrome.

Gillespie KM, Dix RJ, Williams AJ, Newton R, Robinson ZF, Bingley PJ, Gale EA, Shield JP. Gillespie KM, et al. Diabetes. 2006 Nov;55(11):3185-8. doi: 10.2337/db06-0856. Diabetes. 2006. PMID: 17065360

9

Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2.

Williams AJ, Aitken RJ, Chandler MA, Gillespie KM, Lampasona V, Bingley PJ. Williams AJ, et al. Diabetologia. 2008 Aug;51(8):1444-8. doi: 10.1007/s00125-008-1047-3. Epub 2008 May 27. Diabetologia. 2008. PMID: 18504544

10

The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort.

Long AE, Gooneratne AT, Rokni S, Williams AJ, Bingley PJ. Long AE, et al. J Clin Endocrinol Metab. 2012 Feb;97(2):632-7. doi: 10.1210/jc.2011-1952. Epub 2011 Dec 7. J Clin Endocrinol Metab. 2012. PMID: 22162482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page